Evaluation of adenoviral vascular endothelial growth factor-activated chitosan/hydroxyapatite scaffold for engineering vascularized bone tissue using human osteoblasts: In vitro and in vivo studies

Journal of Biomaterials Applications

Volumn 29, Issue 5, 2014, Pages 748-760

  Koç, Aysel ^a   Finkenzeller, Günter ^b   Elçin, A Eser ^a   Stark, G Björn ^b   Elçin, Y Murat ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

adenoviral vector; angiogenesis; Bone tissue engineering; chitosan; gene therapy; human osteoblasts; hydroxyapatite; rat; scaffold; vascular endothelial growth factor

Indexed keywords

BIOCOMPATIBILITY; BONE; CELL ENGINEERING; CHITOSAN; ENDOTHELIAL CELLS; GENE THERAPY; GREEN MANUFACTURING; HYDROXYAPATITE; OXYGEN SUPPLY; PORE SIZE; RATING; SCAFFOLDS; TISSUE; TISSUE REGENERATION;

ADENOVIRAL VECTORS; ANGIOGENESIS; BONE TISSUE ENGINEERING; HUMAN OSTEOBLAST; VASCULAR ENDOTHELIAL GROWTH FACTOR;

SCAFFOLDS (BIOLOGY);

ADENOVIRUS VECTOR; ALKALINE PHOSPHATASE; CHITOSAN; GREEN FLUORESCENT PROTEIN; HYDROXYAPATITE; MOLECULAR SCAFFOLD; OSTEONECTIN; VASCULOTROPIN; BIOMATERIAL; VASCULOTROPIN A;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; BONE MINERALIZATION; BONE REGENERATION; BONE TISSUE; CAPILLARY DENSITY; CELL ADHESION; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FREEZE DRYING; GENE ACTIVATION; HISTOCHEMISTRY; HUMAN; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; NANOFABRICATION; NONHUMAN; OSTEOBLAST; PARTICLE SIZE; PHENOTYPE; PROTEIN EXPRESSION; RAT; TISSUE ENGINEERING; ADENOVIRIDAE; ANIMAL; BONE; BONE DEVELOPMENT; CHEMISTRY; CONFOCAL MICROSCOPY; CYTOLOGY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROCEDURES; REGENERATION; SCANNING ELECTRON MICROSCOPY; TISSUE SCAFFOLD; WISTAR RAT;

ADENOVIRIDAE; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; CELL PROLIFERATION; CHITOSAN; DURAPATITE; FREEZE DRYING; HUMANS; IN VITRO TECHNIQUES; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; NEOVASCULARIZATION, PATHOLOGIC; OSTEOBLASTS; OSTEOGENESIS; PHENOTYPE; RATS; RATS, WISTAR; REGENERATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84908869944     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328214544769     Document Type: Article

References (45)

1. Barnes GL, Kostenuik PJ, Gerstenfeld LC, et al. Growth factor regulation of fracture repair. J Bone Miner Res. 1999 ; 14: 1805-1815
2. Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999 ; 13: 9-22
3. Nguyen LH, Annabi N, Nikkhah M, et al. Vascularized bone tissue engineering: approaches for potential improvement. Tissue Eng Part B Rev. 2012 ; 18: 363-382
4. Elcin YM, Dixit V, Gitnick G. Extensive in vivo angiogenesis from the controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing. Artif Organs. 2001 ; 25: 558-565
5. Elcin AE, Elcin YM. Localized angiogenesis induced by human vascular endothelial growth factor-activated PLGA sponge. Tissue Eng. 2006 ; 12 (4). 959-968
6. Crystal RG. Transfer of genes to humans: early lessons and obstacles to success. Science. 1995 ; 270: 404-410
7. Kootstra NA, Verma IM. Gene therapy with viral vectors. Annu Rev Pharmacol Toxicol. 2003 ; 43: 413-439
8. Jin Q, Anusaksathien O, Webb SA, et al. Gene therapy of bone morphogenetic protein for periodontal tissue engineering. J Periodontol. 2003 ; 74: 202-213
9. Nobuhiro A, Lee Y-P, Sato M, et al. Enhancement of bone repair with a helper-dependent adenoviral transfer of bone morphogenetic protein-2. Biochem Bioph Res Co. 2002 ; 297: 523-527
10. Fang J, Zhu YY, Smiley E, et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA. 1996 ; 93 (12). 5753-5758
11. Chandler LA, Ma C, Gonzalez AM, et al. Matrix-enabled gene transfer for cutaneous wound repair. Wound Repair Regen. 2000 ; 8 (6). 473-479
12. Schek RM, Hollister SJ, Krebsbach PH. Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy. Mol Ther. 2004 ; 9 (1). 130-138
13. Koping-Hoggard M, Tubulekas I, Guan H, et al. Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther. 2001 ; 8: 1108-1121
14. Huang M, Khor E, Lim L-Y. Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res. 2004 ; 21: 344-353
15. Kowapradit J, Opanasopit P, Ngawhirunpat T, et al. In vitro permeability enhancement in intestinal epithelial cells (Caco-2) monolayer of water soluble quaternary ammonium chitosan derivatives. AAPS Pharm Sci Tech. 2010 ; 11: 497-508
16. Loh JW, Yeoh G, Saunders M, et al. Uptake and cytotoxicity of chitosan nanoparticles in human liver cells. Toxicol Appl Pharm. 2010 ; 249: 148-157
17. Seo YJ, Lee JY, Park YJ, et al. Chitosan sponges as tissue engineering scaffolds for bone formation. Biotechnol Lett. 2004 ; 26: 1037-1041
18. Bojar W, Kucharska M, Ciach T, et al. Bone regeneration potential of the new chitosan-based alloplastic biomaterial. J Biomater Appl. 2014 ; 28: 1060-1068
19. Kim HW, Kim HE, Vehid S. Stimulation of osteoblast responses to biomimetic nanocomposites of gelatin-hydroxyapatite for tissue engineering scaffolds. Biomaterials. 2005 ; 26: 5221-5230
20. Zugravu MV, Smith RA, Reves BT, et al. Physical properties and in vitro evaluation of collagen-chitosan-calcium phosphate microparticle-based scaffolds for bone tissue regeneration. J Biomater Appl. 2013 ; 28: 566-579
21. Kong LJ, Gao Y, Lu GY, et al. A study on the bioactivity of chitosan/nano-hydroxyapatite composite scaffolds for bone tissue engineering. Eur Polym J. 2006 ; 42: 3171-3179
22. Inanc B, Elcin AE, Elcin YM. Effect of osteogenic induction on the in vitro differentiation of human embryonic stem cells cocultured with periodontal ligament fibroblasts. Artif Organs. 2007 ; 31 (11). 792-800
23. Mayer H, Bertram H, Lindenmaier W, et al. Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem. 2005 ; 95: 827-839
24. Wenger A, Stahl A, Weber H, et al. Modulation of in vitro angiogenesis in a three-dimensional spheroidal coculture model for bone tissue engineering. Tissue Eng. 2004 ; 10: 1536-1547
25. Koc A, Emin N, Elcin AE, et al. In vitro osteogenic differentiation of rat mesenchymal stem cells in a microgravity bioreactor. J Bioact Compat Pol. 2008 ; 23 (3). 244-261
26. Elcin YM, Elcin AE, Pappas GD. Functional and morphological characteristics of bovine adrenal chromaffin cells on macroporous poly(D,L-lactide-co-glycolide) scaffolds. Tissue Eng. 2003 ; 9 (5). 1047-1056
27. Inanc B, Elcin AE, Koc A, et al. Encapsulation and osteoinduction of human periodontal ligament fibroblasts in chitosan-hydroxyapatite microspheres. J Biomed Mater Res A. 2007 ; 82 (4). 917-926
28. Linn T, Erb D, Schneider D, et al. Polymers for induction of revascularisation in the rat fascial flap: application of vascular endothelial growth factor and pancreatic cell lines. Cell Transplant. 2003 ; 12: 769-778
29. Mead R The design of experiments. Cambridge, New York: Cambridge University Press ; 1988 :
30. Fuchs S, Hofmann A, Kirkpatrick CJ. Microvessel-like structures from outgrowth endothelial cells from human peripheral blood in 2-dimensional and 3-dimensional co-cultures with osteoblastic lineage cells. Tissue Eng. 2007 ; 13: 2577-2588
31. Koob S, Torio-Padron N, Stark B, et al. Bone formation and neovascularization mediated by mesenchymal stem cells and endothelial cells in critical-sized calvarial defects. Tissue Eng Part A. 2011 ; 17 (3-4). 311-321
32. Gerber HP, Vu TH, Ryan AM, et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med. 1999 ; 5: 623-628
33. Street J, Bao M, deGuzman L, et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA. 2002 ; 99: 9656-9661
34. Monahan PE, Samulski RJ. AAV vectors: is clinical success on the horizon?. Gene Therapy. 2000 ; 7: 24-30
35. Maione D, Della-Rocca C, Giannetti P, et al. An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus. Proc Natl Acad Sci USA. 2001 ; 98: 5986-5991
36. Molinier-Frenkel V, Gahery-Segard H, Mehtali M, et al. Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes. J Virol. 2000 ; 74: 7678-7682
37. Rosenfeld MA, Siegfried W, Yoshimura K, et al. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science. 1991 ; 252: 431-434
38. Zhang Y, Cheng X, Wang J, et al. Novel chitosan/collagen scaffold containing transforming growth factor-b1 DNA for periodontal tissue engineering. Biochem Bioph Res Co. 2006 ; 344: 362-369
39. Zhao F, Yin Y, Lu WW, et al. Preparation and histological evaluation of biomimetic three-dimensional hydroxyapatite/chitosan-gelatin network composite scaffolds. Biomaterials. 2002 ; 23: 3227-3234
40. Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials. 2005 ; 26: 5474-5491
41. Thein-Han WW, Misra RDK. Biomimetic chitosan-nanohydroxyapatite composite scaffolds for bone tissue engineering. Acta Biomater. 2009 ; 5: 1182-1197
42. Geiger F, Bertram H, Berger I, et al. Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res. 2005 ; 20: 2028-2035
43. Hou H, Zhang X, Tang T, et al. Enhancement of bone formation by genetically-engineered bone marrow stromal cells expressing BMP-2, VEGF and angiopoietin-1. Biotechnol Lett. 2009 ; 31: 1183-1189
44. Keeney M, van den Beucken JJJP, van der Kraan PM, et al. The ability of a collagen/calcium phosphate scaffold to act as its own vector for gene delivery and to promote bone formation via transfection with VEGF165. Biomaterials. 2010 ; 31: 2893-2902
45. Henry TD, Rocha-Singh K, Isner JM, et al. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am Heart J. 2001 ; 142: 872-880